nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralidoxime—ACHE—Irinotecan—stomach cancer	0.551	0.624	CbGbCtD
Pralidoxime—BCHE—Irinotecan—stomach cancer	0.332	0.376	CbGbCtD
Pralidoxime—BCHE—diaphragm—stomach cancer	0.0153	0.635	CbGeAlD
Pralidoxime—ACHE—Acetylcholine Synthesis—PDHA1—stomach cancer	0.00406	0.142	CbGpPWpGaD
Pralidoxime—Haemoglobin—Floxuridine—stomach cancer	0.00304	0.0471	CcSEcCtD
Pralidoxime—Haemorrhage—Floxuridine—stomach cancer	0.00302	0.0468	CcSEcCtD
Pralidoxime—Drowsiness—Mitomycin—stomach cancer	0.00264	0.0409	CcSEcCtD
Pralidoxime—Inflammation—Fluorouracil—stomach cancer	0.00203	0.0314	CcSEcCtD
Pralidoxime—Vision blurred—Mitomycin—stomach cancer	0.00195	0.0301	CcSEcCtD
Pralidoxime—BCHE—hematopoietic system—stomach cancer	0.00159	0.0662	CbGeAlD
Pralidoxime—Somnolence—Mitomycin—stomach cancer	0.0015	0.0232	CcSEcCtD
Pralidoxime—Inflammation—Docetaxel—stomach cancer	0.00146	0.0226	CcSEcCtD
Pralidoxime—Pain—Mitomycin—stomach cancer	0.00144	0.0223	CcSEcCtD
Pralidoxime—Inflammation—Capecitabine—stomach cancer	0.00142	0.0219	CcSEcCtD
Pralidoxime—BCHE—smooth muscle tissue—stomach cancer	0.0014	0.0583	CbGeAlD
Pralidoxime—Hyperventilation—Epirubicin—stomach cancer	0.00139	0.0215	CcSEcCtD
Pralidoxime—Headache—Floxuridine—stomach cancer	0.00135	0.0208	CcSEcCtD
Pralidoxime—ACHE—lymph node—stomach cancer	0.00129	0.0535	CbGeAlD
Pralidoxime—Hyperventilation—Doxorubicin—stomach cancer	0.00129	0.0199	CcSEcCtD
Pralidoxime—Nausea—Floxuridine—stomach cancer	0.00128	0.0198	CcSEcCtD
Pralidoxime—Muscular weakness—Fluorouracil—stomach cancer	0.00126	0.0195	CcSEcCtD
Pralidoxime—Dizziness—Mitomycin—stomach cancer	0.00111	0.0173	CcSEcCtD
Pralidoxime—BCHE—digestive system—stomach cancer	0.00111	0.0461	CbGeAlD
Pralidoxime—Headache—Mitomycin—stomach cancer	0.00106	0.0164	CcSEcCtD
Pralidoxime—Inflammation—Methotrexate—stomach cancer	0.00105	0.0163	CcSEcCtD
Pralidoxime—Haemoglobin—Irinotecan—stomach cancer	0.00104	0.016	CcSEcCtD
Pralidoxime—Haemorrhage—Irinotecan—stomach cancer	0.00103	0.016	CcSEcCtD
Pralidoxime—BCHE—bone marrow—stomach cancer	0.00102	0.0425	CbGeAlD
Pralidoxime—Nausea—Mitomycin—stomach cancer	0.001	0.0155	CcSEcCtD
Pralidoxime—Diplopia—Capecitabine—stomach cancer	0.000997	0.0154	CcSEcCtD
Pralidoxime—Haemoglobin—Fluorouracil—stomach cancer	0.000992	0.0154	CcSEcCtD
Pralidoxime—Haemorrhage—Fluorouracil—stomach cancer	0.000987	0.0153	CcSEcCtD
Pralidoxime—Inflammation—Epirubicin—stomach cancer	0.000986	0.0153	CcSEcCtD
Pralidoxime—BCHE—endocrine gland—stomach cancer	0.000916	0.0381	CbGeAlD
Pralidoxime—Inflammation—Doxorubicin—stomach cancer	0.000913	0.0141	CcSEcCtD
Pralidoxime—Muscular weakness—Capecitabine—stomach cancer	0.000879	0.0136	CcSEcCtD
Pralidoxime—BCHE—liver—stomach cancer	0.000826	0.0343	CbGeAlD
Pralidoxime—Vision blurred—Fluorouracil—stomach cancer	0.00081	0.0125	CcSEcCtD
Pralidoxime—ACHE—Melatonin metabolism and effects—ADRB1—stomach cancer	0.000764	0.0267	CbGpPWpGaD
Pralidoxime—Haemoglobin—Docetaxel—stomach cancer	0.000716	0.0111	CcSEcCtD
Pralidoxime—Haemorrhage—Docetaxel—stomach cancer	0.000712	0.011	CcSEcCtD
Pralidoxime—Diplopia—Epirubicin—stomach cancer	0.000695	0.0108	CcSEcCtD
Pralidoxime—Haemoglobin—Capecitabine—stomach cancer	0.000693	0.0107	CcSEcCtD
Pralidoxime—Haemorrhage—Capecitabine—stomach cancer	0.00069	0.0107	CcSEcCtD
Pralidoxime—Tachycardia—Fluorouracil—stomach cancer	0.000684	0.0106	CcSEcCtD
Pralidoxime—Somnolence—Irinotecan—stomach cancer	0.000651	0.0101	CcSEcCtD
Pralidoxime—BCHE—Irinotecan Pathway—APC—stomach cancer	0.000648	0.0227	CbGpPWpGaD
Pralidoxime—Diplopia—Doxorubicin—stomach cancer	0.000643	0.00995	CcSEcCtD
Pralidoxime—BCHE—lymph node—stomach cancer	0.000633	0.0263	CbGeAlD
Pralidoxime—Pain—Irinotecan—stomach cancer	0.000626	0.00969	CcSEcCtD
Pralidoxime—Somnolence—Fluorouracil—stomach cancer	0.000623	0.00965	CcSEcCtD
Pralidoxime—Muscular weakness—Epirubicin—stomach cancer	0.000613	0.00949	CcSEcCtD
Pralidoxime—Pain—Fluorouracil—stomach cancer	0.0006	0.00928	CcSEcCtD
Pralidoxime—ACHE—Peptide hormone metabolism—CDX2—stomach cancer	0.000592	0.0207	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MYT1—stomach cancer	0.00059	0.0206	CbGpPWpGaD
Pralidoxime—Drowsiness—Methotrexate—stomach cancer	0.000572	0.00886	CcSEcCtD
Pralidoxime—Muscular weakness—Doxorubicin—stomach cancer	0.000567	0.00878	CcSEcCtD
Pralidoxime—Vision blurred—Capecitabine—stomach cancer	0.000566	0.00876	CcSEcCtD
Pralidoxime—Drowsiness—Epirubicin—stomach cancer	0.000535	0.00829	CcSEcCtD
Pralidoxime—BCHE—Peptide hormone metabolism—CDX2—stomach cancer	0.000528	0.0185	CbGpPWpGaD
Pralidoxime—Haemoglobin—Methotrexate—stomach cancer	0.000516	0.00799	CcSEcCtD
Pralidoxime—Haemorrhage—Methotrexate—stomach cancer	0.000513	0.00795	CcSEcCtD
Pralidoxime—Drowsiness—Doxorubicin—stomach cancer	0.000495	0.00767	CcSEcCtD
Pralidoxime—Tachycardia—Docetaxel—stomach cancer	0.000494	0.00765	CcSEcCtD
Pralidoxime—Dizziness—Irinotecan—stomach cancer	0.000484	0.0075	CcSEcCtD
Pralidoxime—Haemoglobin—Epirubicin—stomach cancer	0.000483	0.00748	CcSEcCtD
Pralidoxime—Haemorrhage—Epirubicin—stomach cancer	0.000481	0.00744	CcSEcCtD
Pralidoxime—Tachycardia—Capecitabine—stomach cancer	0.000478	0.0074	CcSEcCtD
Pralidoxime—Dizziness—Fluorouracil—stomach cancer	0.000464	0.00718	CcSEcCtD
Pralidoxime—Headache—Irinotecan—stomach cancer	0.000459	0.0071	CcSEcCtD
Pralidoxime—Somnolence—Docetaxel—stomach cancer	0.00045	0.00697	CcSEcCtD
Pralidoxime—Haemoglobin—Doxorubicin—stomach cancer	0.000447	0.00692	CcSEcCtD
Pralidoxime—Haemorrhage—Doxorubicin—stomach cancer	0.000445	0.00688	CcSEcCtD
Pralidoxime—Headache—Fluorouracil—stomach cancer	0.000439	0.0068	CcSEcCtD
Pralidoxime—Nausea—Irinotecan—stomach cancer	0.000435	0.00673	CcSEcCtD
Pralidoxime—Pain—Docetaxel—stomach cancer	0.000433	0.0067	CcSEcCtD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TFF1—stomach cancer	0.000427	0.0149	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—GADD45A—stomach cancer	0.000425	0.0149	CbGpPWpGaD
Pralidoxime—Vision blurred—Methotrexate—stomach cancer	0.000421	0.00652	CcSEcCtD
Pralidoxime—Pain—Capecitabine—stomach cancer	0.000419	0.00649	CcSEcCtD
Pralidoxime—Nausea—Fluorouracil—stomach cancer	0.000417	0.00645	CcSEcCtD
Pralidoxime—Vision blurred—Epirubicin—stomach cancer	0.000394	0.0061	CcSEcCtD
Pralidoxime—Agitation—Epirubicin—stomach cancer	0.000384	0.00595	CcSEcCtD
Pralidoxime—Vision blurred—Doxorubicin—stomach cancer	0.000365	0.00565	CcSEcCtD
Pralidoxime—Agitation—Doxorubicin—stomach cancer	0.000356	0.00551	CcSEcCtD
Pralidoxime—ACHE—Peptide hormone metabolism—PAX6—stomach cancer	0.000345	0.0121	CbGpPWpGaD
Pralidoxime—Dizziness—Docetaxel—stomach cancer	0.000335	0.00518	CcSEcCtD
Pralidoxime—Tachycardia—Epirubicin—stomach cancer	0.000333	0.00516	CcSEcCtD
Pralidoxime—Somnolence—Methotrexate—stomach cancer	0.000324	0.00502	CcSEcCtD
Pralidoxime—Dizziness—Capecitabine—stomach cancer	0.000324	0.00502	CcSEcCtD
Pralidoxime—Headache—Docetaxel—stomach cancer	0.000317	0.00491	CcSEcCtD
Pralidoxime—Pain—Methotrexate—stomach cancer	0.000312	0.00483	CcSEcCtD
Pralidoxime—Tachycardia—Doxorubicin—stomach cancer	0.000308	0.00477	CcSEcCtD
Pralidoxime—BCHE—Peptide hormone metabolism—PAX6—stomach cancer	0.000308	0.0108	CbGpPWpGaD
Pralidoxime—Headache—Capecitabine—stomach cancer	0.000307	0.00475	CcSEcCtD
Pralidoxime—ACHE—Peptide hormone metabolism—ACE—stomach cancer	0.000306	0.0107	CbGpPWpGaD
Pralidoxime—Somnolence—Epirubicin—stomach cancer	0.000303	0.0047	CcSEcCtD
Pralidoxime—Nausea—Docetaxel—stomach cancer	0.000301	0.00465	CcSEcCtD
Pralidoxime—Pain—Epirubicin—stomach cancer	0.000292	0.00452	CcSEcCtD
Pralidoxime—Nausea—Capecitabine—stomach cancer	0.000291	0.00451	CcSEcCtD
Pralidoxime—Somnolence—Doxorubicin—stomach cancer	0.000281	0.00435	CcSEcCtD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—BID—stomach cancer	0.000279	0.00977	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—SLC1A2—stomach cancer	0.000278	0.00972	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—ACE—stomach cancer	0.000273	0.00956	CbGpPWpGaD
Pralidoxime—Pain—Doxorubicin—stomach cancer	0.00027	0.00418	CcSEcCtD
Pralidoxime—ACHE—Monoamine Transport—IL1B—stomach cancer	0.000265	0.00927	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—PLAU—stomach cancer	0.000259	0.00905	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP10—stomach cancer	0.000257	0.00899	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—FST—stomach cancer	0.000257	0.00899	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—SLC1A2—stomach cancer	0.000248	0.00867	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—CDK4—stomach cancer	0.000244	0.00855	CbGpPWpGaD
Pralidoxime—Dizziness—Methotrexate—stomach cancer	0.000241	0.00373	CcSEcCtD
Pralidoxime—Headache—Methotrexate—stomach cancer	0.000229	0.00354	CcSEcCtD
Pralidoxime—Dizziness—Epirubicin—stomach cancer	0.000226	0.0035	CcSEcCtD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	0.000224	0.00784	CbGpPWpGaD
Pralidoxime—Nausea—Methotrexate—stomach cancer	0.000217	0.00335	CcSEcCtD
Pralidoxime—Headache—Epirubicin—stomach cancer	0.000214	0.00331	CcSEcCtD
Pralidoxime—ACHE—Metabolism of proteins—NOP56—stomach cancer	0.000213	0.00745	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—DPAGT1—stomach cancer	0.000213	0.00745	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—SLC1A2—stomach cancer	0.000213	0.00745	CbGpPWpGaD
Pralidoxime—Dizziness—Doxorubicin—stomach cancer	0.000209	0.00323	CcSEcCtD
Pralidoxime—ACHE—ATF-2 transcription factor network—MMP2—stomach cancer	0.000204	0.00713	CbGpPWpGaD
Pralidoxime—Nausea—Epirubicin—stomach cancer	0.000203	0.00314	CcSEcCtD
Pralidoxime—Headache—Doxorubicin—stomach cancer	0.000198	0.00306	CcSEcCtD
Pralidoxime—ACHE—Metabolism of proteins—EEF1A2—stomach cancer	0.000195	0.00681	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	0.000195	0.00681	CbGpPWpGaD
Pralidoxime—ACHE—Monoamine Transport—TNF—stomach cancer	0.000192	0.00673	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—NOP56—stomach cancer	0.00019	0.00665	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—DPAGT1—stomach cancer	0.00019	0.00665	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—SLC1A2—stomach cancer	0.00019	0.00664	CbGpPWpGaD
Pralidoxime—Nausea—Doxorubicin—stomach cancer	0.000188	0.00291	CcSEcCtD
Pralidoxime—ACHE—Metabolism of proteins—MUC6—stomach cancer	0.000181	0.00634	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000178	0.00623	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	0.000175	0.00611	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—EEF1A2—stomach cancer	0.000174	0.00608	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—CXCL8—stomach cancer	0.000169	0.00593	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	0.000166	0.00582	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—HSPA8—stomach cancer	0.000166	0.00581	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—MUC6—stomach cancer	0.000161	0.00565	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CCT7—stomach cancer	0.000161	0.00565	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000159	0.00556	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—CCND1—stomach cancer	0.000158	0.00552	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—JUN—stomach cancer	0.000157	0.00551	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—EEF1A1—stomach cancer	0.000154	0.00539	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—TUBA1C—stomach cancer	0.000154	0.00539	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	0.000152	0.00532	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000149	0.00522	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—MAPK8—stomach cancer	0.000149	0.00521	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—HSPA8—stomach cancer	0.000148	0.00518	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CCT7—stomach cancer	0.000144	0.00504	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—EEF1A1—stomach cancer	0.000137	0.00481	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—TUBA1C—stomach cancer	0.000137	0.00481	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000133	0.00466	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—EXOSC5—stomach cancer	0.000133	0.00465	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—MAPK3—stomach cancer	0.00013	0.00455	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—HSPA8—stomach cancer	0.000127	0.00445	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	0.000127	0.00444	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	0.000125	0.00436	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—MAPK1—stomach cancer	0.000124	0.00433	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ACAD8—stomach cancer	0.000123	0.00431	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	0.000122	0.00428	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.00012	0.00421	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—EXOSC5—stomach cancer	0.000119	0.00415	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—HSPA8—stomach cancer	0.000113	0.00397	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000113	0.00396	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CDX2—stomach cancer	0.000112	0.00391	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ACAD8—stomach cancer	0.00011	0.00384	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GMPR2—stomach cancer	0.00011	0.00384	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPL18—stomach cancer	0.00011	0.00384	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPL13—stomach cancer	0.00011	0.00384	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000107	0.00376	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000106	0.00371	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000105	0.00366	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPS21—stomach cancer	0.000102	0.00358	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPS15—stomach cancer	0.000102	0.00358	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000101	0.00353	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SUCLG1—stomach cancer	0.0001	0.00351	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—IDH3B—stomach cancer	0.0001	0.00351	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CDX2—stomach cancer	9.98e-05	0.00349	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GMPR2—stomach cancer	9.79e-05	0.00343	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPL18—stomach cancer	9.78e-05	0.00342	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPL13—stomach cancer	9.78e-05	0.00342	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	9.55e-05	0.00334	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—IL6—stomach cancer	9.51e-05	0.00333	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—MUC2—stomach cancer	9.51e-05	0.00333	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	9.45e-05	0.00331	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—RORA—stomach cancer	9.34e-05	0.00327	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NDUFV1—stomach cancer	9.33e-05	0.00327	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NDUFS1—stomach cancer	9.33e-05	0.00327	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPS21—stomach cancer	9.13e-05	0.00319	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPS15—stomach cancer	9.13e-05	0.00319	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	9.12e-05	0.00319	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—PRKCB—stomach cancer	9.05e-05	0.00317	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	8.99e-05	0.00314	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—IDH3B—stomach cancer	8.95e-05	0.00313	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SUCLG1—stomach cancer	8.95e-05	0.00313	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—MUC2—stomach cancer	8.48e-05	0.00297	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	8.37e-05	0.00293	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NDUFV1—stomach cancer	8.32e-05	0.00291	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NDUFS1—stomach cancer	8.32e-05	0.00291	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PGLS—stomach cancer	8.32e-05	0.00291	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—BLVRB—stomach cancer	8.32e-05	0.00291	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPL15—stomach cancer	8.31e-05	0.00291	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—HSPD1—stomach cancer	8.31e-05	0.00291	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	8.14e-05	0.00285	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—PRKCB—stomach cancer	8.07e-05	0.00283	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPAP2A—stomach cancer	7.93e-05	0.00278	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPS26—stomach cancer	7.75e-05	0.00271	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	7.63e-05	0.00267	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—BLVRB—stomach cancer	7.42e-05	0.0026	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PGLS—stomach cancer	7.42e-05	0.0026	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—HSPD1—stomach cancer	7.42e-05	0.0026	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPL15—stomach cancer	7.42e-05	0.0026	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPAP2A—stomach cancer	7.08e-05	0.00248	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CKB—stomach cancer	7.07e-05	0.00247	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CA1—stomach cancer	7.07e-05	0.00247	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NDUFA2—stomach cancer	7.07e-05	0.00247	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—FBP1—stomach cancer	7.07e-05	0.00247	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—IGFBP3—stomach cancer	7.02e-05	0.00246	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	6.98e-05	0.00244	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—PRKCB—stomach cancer	6.93e-05	0.00243	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPS26—stomach cancer	6.92e-05	0.00242	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	6.82e-05	0.00239	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	6.81e-05	0.00238	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PLIN2—stomach cancer	6.65e-05	0.00233	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPS19—stomach cancer	6.59e-05	0.00231	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—PAX6—stomach cancer	6.52e-05	0.00228	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CA2—stomach cancer	6.47e-05	0.00226	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	6.46e-05	0.00226	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CA1—stomach cancer	6.31e-05	0.00221	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CKB—stomach cancer	6.31e-05	0.00221	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—FBP1—stomach cancer	6.31e-05	0.00221	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NDUFA2—stomach cancer	6.31e-05	0.00221	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NT5E—stomach cancer	6.3e-05	0.00221	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PGAM1—stomach cancer	6.3e-05	0.00221	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—IGFBP3—stomach cancer	6.27e-05	0.00219	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—PRKCB—stomach cancer	6.19e-05	0.00216	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	6.16e-05	0.00216	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	6.15e-05	0.00215	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALDH7A1—stomach cancer	6.01e-05	0.0021	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PLCE1—stomach cancer	6.01e-05	0.0021	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	5.96e-05	0.00209	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PLIN2—stomach cancer	5.93e-05	0.00208	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPS19—stomach cancer	5.88e-05	0.00206	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—RPS6—stomach cancer	5.83e-05	0.00204	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	5.82e-05	0.00204	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—PAX6—stomach cancer	5.82e-05	0.00204	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ACE—stomach cancer	5.78e-05	0.00202	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CA2—stomach cancer	5.77e-05	0.00202	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—UMPS—stomach cancer	5.76e-05	0.00202	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NT5E—stomach cancer	5.62e-05	0.00197	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PGAM1—stomach cancer	5.62e-05	0.00197	CbGpPWpGaD
Pralidoxime—ACHE—Phospholipid metabolism—PIK3CA—stomach cancer	5.44e-05	0.00191	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	5.37e-05	0.00188	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PLCE1—stomach cancer	5.36e-05	0.00188	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALDH7A1—stomach cancer	5.36e-05	0.00188	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ECHS1—stomach cancer	5.36e-05	0.00188	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PDHA1—stomach cancer	5.36e-05	0.00188	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—RPS6—stomach cancer	5.2e-05	0.00182	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ACE—stomach cancer	5.16e-05	0.00181	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—UMPS—stomach cancer	5.14e-05	0.0018	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	5.08e-05	0.00178	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—TYMP—stomach cancer	5.04e-05	0.00176	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—FADS1—stomach cancer	5.04e-05	0.00176	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	4.94e-05	0.00173	CbGpPWpGaD
Pralidoxime—BCHE—Phospholipid metabolism—PIK3CA—stomach cancer	4.86e-05	0.0017	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	4.84e-05	0.00169	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	4.84e-05	0.00169	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PDHA1—stomach cancer	4.78e-05	0.00167	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ECHS1—stomach cancer	4.78e-05	0.00167	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SREBF2—stomach cancer	4.72e-05	0.00165	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—MAPK1—stomach cancer	4.66e-05	0.00163	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—RORA—stomach cancer	4.66e-05	0.00163	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	4.61e-05	0.00161	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	4.57e-05	0.0016	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—TYMP—stomach cancer	4.49e-05	0.00157	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—FADS1—stomach cancer	4.49e-05	0.00157	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALDOB—stomach cancer	4.37e-05	0.00153	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SREBF2—stomach cancer	4.21e-05	0.00147	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	4.2e-05	0.00147	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—MAPK1—stomach cancer	4.16e-05	0.00146	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—RORA—stomach cancer	4.16e-05	0.00146	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	4.12e-05	0.00144	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	4.11e-05	0.00144	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALOX5—stomach cancer	4.06e-05	0.00142	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	4.06e-05	0.00142	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—DPYD—stomach cancer	4e-05	0.0014	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALDOB—stomach cancer	3.9e-05	0.00136	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—HRAS—stomach cancer	3.74e-05	0.00131	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.67e-05	0.00129	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.67e-05	0.00128	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALOX5—stomach cancer	3.62e-05	0.00127	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.62e-05	0.00127	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—MAPK1—stomach cancer	3.57e-05	0.00125	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—DPYD—stomach cancer	3.56e-05	0.00125	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTT1—stomach cancer	3.53e-05	0.00124	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP2A6—stomach cancer	3.49e-05	0.00122	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AKR1C3—stomach cancer	3.4e-05	0.00119	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—HRAS—stomach cancer	3.34e-05	0.00117	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ENO1—stomach cancer	3.31e-05	0.00116	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.26e-05	0.00114	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.23e-05	0.00113	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—MAPK1—stomach cancer	3.19e-05	0.00112	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTT1—stomach cancer	3.15e-05	0.0011	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP2A6—stomach cancer	3.12e-05	0.00109	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AKR1C3—stomach cancer	3.03e-05	0.00106	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ENO1—stomach cancer	2.95e-05	0.00103	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CD44—stomach cancer	2.94e-05	0.00103	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.9e-05	0.00102	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—MMP2—stomach cancer	2.87e-05	0.00101	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—HRAS—stomach cancer	2.87e-05	0.001	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.85e-05	0.000997	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CD44—stomach cancer	2.62e-05	0.000917	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—MMP2—stomach cancer	2.56e-05	0.000897	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—HRAS—stomach cancer	2.56e-05	0.000895	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.54e-05	0.000889	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPP2R1A—stomach cancer	2.5e-05	0.000874	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTP1—stomach cancer	2.45e-05	0.000857	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HMOX1—stomach cancer	2.42e-05	0.000845	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CXCL8—stomach cancer	2.39e-05	0.000835	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—TYMS—stomach cancer	2.28e-05	0.000797	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GSTM1—stomach cancer	2.25e-05	0.000788	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPP2R1A—stomach cancer	2.23e-05	0.000779	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTP1—stomach cancer	2.18e-05	0.000765	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HMOX1—stomach cancer	2.15e-05	0.000754	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CXCL8—stomach cancer	2.13e-05	0.000745	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ERCC2—stomach cancer	2.12e-05	0.00074	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—TYMS—stomach cancer	2.03e-05	0.000711	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GSTM1—stomach cancer	2.01e-05	0.000703	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—MTHFR—stomach cancer	1.99e-05	0.000696	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ERCC2—stomach cancer	1.89e-05	0.000661	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CAV1—stomach cancer	1.83e-05	0.000642	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—APOA1—stomach cancer	1.83e-05	0.000641	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—MTHFR—stomach cancer	1.77e-05	0.000621	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.75e-05	0.000613	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CAV1—stomach cancer	1.64e-05	0.000573	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—APOA1—stomach cancer	1.63e-05	0.000571	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPARG—stomach cancer	1.61e-05	0.000564	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.56e-05	0.000547	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALB—stomach cancer	1.45e-05	0.000507	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPARG—stomach cancer	1.44e-05	0.000504	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NOS3—stomach cancer	1.39e-05	0.000485	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALB—stomach cancer	1.29e-05	0.000453	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PTGS2—stomach cancer	1.27e-05	0.000444	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NOS3—stomach cancer	1.24e-05	0.000433	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTGS2—stomach cancer	1.13e-05	0.000396	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PIK3CA—stomach cancer	7.81e-06	0.000273	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PIK3CA—stomach cancer	6.96e-06	0.000244	CbGpPWpGaD
